SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSigmaroc. Regulatory News (SRC)

Share Price Information for Sigmaroc. (SRC)

Share Price is delayed by 15 minutes
Get Live Data
125.50    6.20 (5.20%)
Bid:
125.20
Ask:
125.60
Spread: 0.40 (0.319%)
Market Cap: £1.39b
SRC Live PriceLast checked at - London Stock Exchange

Intraday Sigmaroc. Share Chart

Company Update

3 May 2017 07:00

RNS Number : 9749D
SigmaRoc PLC
03 May 2017
 

3 May 2017

 

SigmaRoc plc

 

('SigmaRoc' or the 'Company')

 

Update on Debt Facilities, Appointment of Joint Broker and Option Exercise

 

SigmaRoc plc, the AIM listed construction materials business (AIM: SRC), wishes to update the market on the following items:

 

Santander Debt Facilities

 

SigmaRoc confirms that it has satisfied the conditions in relation to the Santander UK plc ('Santander') debt facilities announced on 21 February 2017. Accordingly, the Company has now signed the £2 million Revolving Credit Facility agreement.

 

The terms and conditions for the £18 million term facility (the 'Term Facility') with Santander have also been agreed. It is envisaged that the Term Facility agreement will be finalised and executed in due course as SigmaRoc pursues its expansion pipeline.

 

Joint Broker to the Company

 

SigmaRoc is pleased to announce the appointment of Berenberg as a Joint Broker to the Company, alongside Zeus Capital Limited, with immediate effect.

 

Option Exercise and Total Voting Rights

 

Additionally, SigmaRoc announces that it has received notification from an option holder to exercise options over 104,059 new ordinary shares of 1 pence each in the capital of the Company (the 'New Ordinary Shares'), at an exercise price of 25 pence per share raising, in aggregate, £26,014.75.

 

Application will be made for the New Ordinary Shares to be admitted to trading on the AIM market of the London Stock Exchange ('Admission'). Admission is expected to occur on or around 8 May 2017.

Following the issue of the New Ordinary Shares, the total issued share capital of the Company consists of 102,705,557 ordinary shares of 1 pence each ('Ordinary Shares') with voting rights. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 102,705,557 and this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

**ENDS**

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please visit www.sigmaroc.com or contact:

 

SigmaRoc plc +44(0)207 129 7828

Max Vermorken

 

Strand Hanson Limited (Nominated and Financial Adviser) +44(0)207 409 3494

James Spinney

James Dance

 

Zeus Capital Limited (Joint Broker) +44(0)203 829 5000

Rob Collins

Alex Wood

 

Berenberg (Joint Broker) +44(0)203 207 7800

Ben Wright

Laure Fine

 

Temple Bar Advisory (Public Relations Advisor) +44(0)207 002 1080

Ed Orlebar

Tom Allison

Alycia MacAskill

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDDGGDURBGBGRD
Date   Source Headline
20th Feb 20253:40 pmRNSTR-1: Notification of Major Holdings
11th Feb 20255:04 pmRNSTR-1: Notification of Major Holdings
7th Feb 20254:53 pmRNSTR-1: Notification of Major Holdings
7th Feb 202510:40 amRNSTR-1: Notification of Major Holdings
7th Feb 20258:15 amRNSDirector Purchases
6th Feb 202511:00 amRNSEBT Share Purchase
6th Feb 20257:00 amRNSResults of Secondary Placing in SigmaRoc
5th Feb 20254:41 pmRNSProposed Placing of Ordinary Shares in SigmaRoc
3rd Feb 20257:00 amRNSYear-end Trading Update
19th Dec 20248:09 amRNSDirector/PDMR Shareholding
12th Dec 20247:00 amRNSCFO Succession
5th Nov 20247:00 amRNSHolding(s) in Company
28th Oct 20247:00 amRNSQ3 Trading Update
7th Oct 20247:00 amRNSShare Purchase by CFO designate
9th Sep 20247:00 amRNSInterim Results, Analyst Briefing & Investor Pres
2nd Sep 20247:00 amRNSCompletion of acquisition of CRH's Polish Lime ops
30th Jul 20247:00 amRNSTrading Update, Notice of Results & Presentations
1st Jul 20247:00 amRNSChange of Nominated Adviser and Broker
1st Jul 20247:00 amRNSStrategic Alliance for Sustainable Limestone in UK
4th Jun 20247:00 amRNSExercise of Call Option on CRH Polish Lime Assets
17th May 20245:03 pmRNSHolding(s) in Company
14th May 20246:10 pmRNSHolding(s) in Company
2nd May 20244:22 pmRNSHolding(s) in Company
25th Apr 202412:12 pmRNSHolding(s) in Company
12th Apr 20241:20 pmRNSResult of AGM
12th Apr 20247:00 amRNSAGM Statement
27th Mar 20247:00 amRNSCompletion of acquisition of UK Lime operations
22nd Mar 20247:00 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirectorate Change
18th Mar 20247:00 amRNSFinal Results, Notice of AGM & Investor Pres
7th Mar 20247:00 amRNSChange of Adviser
6th Mar 20247:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
5th Mar 20242:58 pmRNSHolding(s) in Company
4th Mar 20247:00 amRNSExercise of Option on UK Lime Operations
9th Feb 20247:00 amRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading Update
24th Jan 202410:10 amRNSHolding(s) in Company
9th Jan 20247:00 amRNSHolding(s) in Company
5th Jan 20245:40 pmRNSHolding(s) in Company
5th Jan 20244:01 pmRNSHolding(s) in Company
5th Jan 20244:00 pmRNSHolding(s) in Company
5th Jan 20243:56 pmRNSHolding(s) in Company
4th Jan 20248:30 amRNSHolding(s) in Company
4th Jan 20248:15 amRNSAdmission to AIM
4th Jan 20248:00 amRNSReadmission - SigmaRoc PLC
12th Dec 20234:48 pmRNSHolding(s) in Company
11th Dec 20233:00 pmRNSSchedule One - SigmaRoc plc
11th Dec 20232:00 pmRNSResult of GM & Director / PDMR Dealings
11th Dec 20237:00 amRNSSigmaRoc presenting at MelloMonday & CEO interview
30th Nov 20237:00 amRNSAnalyst Briefing & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.